Clinical Trial Update: Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis

View source ↗

Summary

This completed NCI-sponsored clinical trial investigates tumor markers and factors associated with angiogenesis in inflammatory breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Neoplasms | Status: COMPLETED